Recursion Pharmaceuticals
Recursion Pharmaceuticals is a clinical-stage biotechnology company dedicated to transforming drug discovery by integrating advanced technologies across biology, chemistry, automation, data science, and engineering. Their mission is to decode complex biological systems to develop innovative therapies for diseases with significant unmet needs.
Key Features and Functionality:
- Recursion Operating System (Recursion OS): An AI-native, end-to-end platform that unifies biology, chemistry, and clinical development into a cohesive intelligence system. This platform leverages proprietary multimodal data and purpose-built AI models to accelerate drug discovery and development processes.
- Extensive Proprietary Data: Recursion has amassed over 50 petabytes of proprietary biological and chemical data, including phenomics, transcriptomics, proteomics, ADME, and de-identified patient data. This vast dataset fuels their AI models, enabling the identification of novel therapeutic targets and the development of potential first-in-class and best-in-class treatments.
- Automated Wet Lab: Utilizing robotics and high-throughput experimentation, Recursion conducts millions of wet lab experiments weekly. This automation enhances the efficiency and scalability of their research efforts.
Primary Value and Solutions:
Recursion Pharmaceuticals addresses the high failure rates and lengthy timelines associated with traditional drug discovery by harnessing AI and automation. Their approach has led to significant improvements in speed, efficiency, and cost reduction from hit identification to IND-enabling studies. By decoding complex biological systems, Recursion aims to bring better medicines to patients faster, particularly for conditions with high unmet needs, including aggressive cancers and rare diseases.
